Institutions / Farallon Capital Management LLC / Activity
Activity — Farallon Capital Management LLC
245 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q3 2025 as of | New | Microsoft Corp Common stock | $990.91M | +1.9M | 1,913,135 5.72% of portfolio | high |
| Q3 2025 as of | New | Aon plc Common stock | $812.30M | +2.3M | 2,278,017 4.69% of portfolio | high |
| Q3 2025 as of | New | Exelixis, Inc. Common stock | $805.41M | +19.5M | 19,501,500 4.65% of portfolio | high |
| Q3 2025 as of | New | Amazon.com Inc Common stock | $769.75M | +3.5M | 3,505,700 4.44% of portfolio | high |
| Q3 2025 as of | New | Natera, Inc. Common stock | $684.68M | +4.3M | 4,253,452 3.95% of portfolio | high |
| Q3 2025 as of | New | Revolution Medicines, Inc. Common stock | $683.02M | +14.6M | 14,625,692 3.94% of portfolio | high |
| Q3 2025 as of | New | Unitedhealth Group Inc Common stock | $651.41M | +1.9M | 1,886,500 3.76% of portfolio | high |
| Q3 2025 as of | New | Thermo Fisher Scientific Inc. Common stock | $610.27M | +1.3M | 1,258,241 3.52% of portfolio | high |
| Q3 2025 as of | New | Hims & Hers Health, Inc. Common stock | $609.56M | +10.7M | 10,746,852 3.52% of portfolio | high |
| Q3 2025 as of | New | Walt Disney Co Common stock | $595.28M | +5.2M | 5,198,968 3.44% of portfolio | high |
| Q3 2025 as of | New | Salesforce Inc Common stock | $583.57M | +2.5M | 2,462,310 3.37% of portfolio | high |
| Q3 2025 as of | New | Autodesk, Inc. Common stock | $528.24M | +1.7M | 1,662,852 3.05% of portfolio | high |
| Q4 2025 as of | Exit | Autodesk, Inc. Common stock | $-528.24M | -1.7M -100.00% | 0 | high |
| Q4 2025 as of | New | M2682V108 Common stock | $469.72M | +1.1M | 1,053,040 2.71% of portfolio | high |
| Q4 2025 as of | New | Synopsys Inc Common stock | $469.34M | +999K | 999,200 2.71% of portfolio | high |
| Q3 2025 as of | New | Boston Scientific Corp Common stock | $463.41M | +4.7M | 4,746,557 2.67% of portfolio | high |
| Q3 2025 as of | New | 46438F101 Common stock | $454.53M | +7.0M | 6,992,700 2.62% of portfolio | high |
| Q3 2025 as of | New | Westinghouse Air Brake Technologies Corp Common stock | $442.06M | +2.2M | 2,205,098 2.55% of portfolio | high |
| Q3 2025 as of | New | BridgeBio Pharma, Inc. Common stock | $425.49M | +8.2M | 8,192,000 2.46% of portfolio | high |
| Q3 2025 as of | New | Protagonist Therapeutics Inc Common stock | $411.60M | +6.2M | 6,196,006 2.38% of portfolio | high |
| Q3 2025 as of | New | TransUnion Common stock | $396.45M | +4.7M | 4,732,075 2.29% of portfolio | high |
| Q4 2025 as of | Trim | Thermo Fisher Scientific Inc. Common stock | $-360.74M | -623K -49.48% | 635,685 2.13% of portfolio | high |
| Q4 2025 as of | Trim | TransUnion Common stock | $-347.89M | -4.1M -85.74% | 675,000 0.33% of portfolio | high |
| Q3 2025 as of | New | Aramark Common stock | $345.45M | +9.0M | 8,996,202 1.99% of portfolio | high |
| Q3 2025 as of | New | Intuit Inc. Common stock | $333.32M | +488K | 488,088 1.92% of portfolio | high |
| Q4 2025 as of | Exit | Intuit Inc. Common stock | $-333.32M | -488K -100.00% | 0 | high |
| Q4 2025 as of | Exit | 487836108 Common stock | $-323.47M | -3.9M -100.00% | 0 | high |
| Q3 2025 as of | New | NASDAQ, Inc. Common stock | $320.46M | +3.6M | 3,623,043 1.85% of portfolio | high |
| Q3 2025 as of | New | Analog Devices Inc Common stock | $319.29M | +1.3M | 1,299,500 1.84% of portfolio | high |
| Q4 2025 as of | Exit | Analog Devices Inc Common stock | $-319.29M | -1.3M -100.00% | 0 | high |
| Q4 2025 as of | Trim | Salesforce Inc Common stock | $-318.19M | -1.2M -48.78% | 1,261,177 1.93% of portfolio | high |
| Q3 2025 as of | New | Schwab Charles Corp Common stock | $310.44M | +3.3M | 3,251,657 1.79% of portfolio | high |
| Q4 2025 as of | New | Broadcom Inc. Common stock | $308.86M | +892K | 892,400 1.78% of portfolio | high |
| Q3 2025 as of | New | New York Times Co Common stock | $286.18M | +5.0M | 4,985,745 1.65% of portfolio | high |
| Q3 2025 as of | New | Alphabet Inc. Common stock | $273.00M | +1.1M | 1,120,940 1.58% of portfolio | high |
| Q4 2025 as of | New | KKR & Co. Inc. Common stock | $257.22M | +2.0M | 2,017,700 1.48% of portfolio | high |
| Q4 2025 as of | Add | Boston Scientific Corp Common stock | $256.78M | +2.7M +56.74% | 7,439,564 4.09% of portfolio | high |
| Q3 2025 as of | New | CBRE Group Inc Common stock | $254.62M | +1.6M | 1,616,038 1.47% of portfolio | high |
| Q3 2025 as of | New | McKesson Corp Common stock | $252.70M | +327K | 327,100 1.46% of portfolio | high |
| Q3 2025 as of | New | Beam Therapeutics Inc. Common stock | $244.23M | +10.1M | 10,063,111 1.41% of portfolio | high |
| Q4 2025 as of | Trim | 46438F101 Common stock | $-241.08M | -4.9M -69.44% | 2,137,100 0.61% of portfolio | high |
| Q3 2025 as of | New | Crinetics Pharmaceuticals, Inc. Common stock | $240.32M | +5.8M | 5,770,098 1.39% of portfolio | high |
| Q4 2025 as of | Trim | Hims & Hers Health, Inc. Common stock | $-238.97M | -7.4M -68.48% | 3,386,986 0.63% of portfolio | high |
| Q3 2025 as of | New | 46438R105 Common stock | $234.77M | +7.5M | 7,450,730 1.36% of portfolio | high |
| Q3 2025 as of | New | Agios Pharmaceuticals, Inc. Common stock | $232.05M | +5.8M | 5,781,066 1.34% of portfolio | high |
| Q4 2025 as of | Add | Amazon.com Inc Common stock | $229.48M | +994K +28.36% | 4,499,894 6.00% of portfolio | high |
| Q3 2025 as of | New | Visa Inc Common stock | $204.76M | +600K | 599,810 1.18% of portfolio | high |
| Q4 2025 as of | New | Dayforce, Inc. Common stock | $202.29M | +2.9M | 2,925,000 1.17% of portfolio | high |
| Q4 2025 as of | New | 091749101 Common stock | $198.93M | +3.4M | 3,385,500 1.15% of portfolio | high |
| Q3 2025 as of | New | LQDA Liquidia Corp Common Stock | $194.78M | +8.6M | 8,565,638 1.12% of portfolio | high |